SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-18-003926
Filing Date
2018-04-13
Accepted
2018-04-13 16:45:53
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDED ANNUAL REPORT ndra_10ka.htm 10-K/A 222381
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ndra_ex311.htm EX-31.1 6396
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ndra_ex312.htm EX-31.2 6344
  Complete submission text file 0001654954-18-003926.txt   236245
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37969 | Film No.: 18754799
SIC: 3845 Electromedical & Electrotherapeutic Apparatus